Yamazaki H - Search Results

1

An anti-K-ras ribozyme suppresses oncogene expression and cell growth of human pancreatic cancer.

Sakuma T, Kijima H, Nishi M, Abe Y, Yamazaki H, Mine T, Nakamura M, Ueyama Y. Sakuma T, et al. Among authors: yamazaki h. Tokai J Exp Clin Med. 2004 Jun;29(2):35-42. Tokai J Exp Clin Med. 2004. PMID: 15473338

2

Ribozyme mediated suppression of vascular endothelial growth factor gene expression enhances matrix metalloproteinase 1 expression in a human hepatocellular carcinoma cell line.

Kamochi J, Tokunaga T, Morino F, Nagata J, Tomii Y, Abe Y, Hatanaka H, Kijima H, Yamazaki H, Watanabe N, Matsuzaki S, Ueyama Y, Nakamura M. Kamochi J, et al. Among authors: yamazaki h. Int J Oncol. 2002 Jul;21(1):81-4. Int J Oncol. 2002. PMID: 12063553

3

Correlation between interleukin 10 and vascular endothelial growth factor expression in human esophageal cancer.

Nagata J, Kijima H, Hatanaka H, Tokunaga T, Takagi A, Mine T, Yamazaki H, Nakamura M, Ueyama Y. Nagata J, et al. Among authors: yamazaki h. Int J Mol Med. 2002 Aug;10(2):169-72. Int J Mol Med. 2002. PMID: 12119553

4

Angiopoietin-1 and vascular endothelial growth factor expression in human esophageal cancer.

Nagata J, Kijima H, Hatanaka H, Tokunaga T, Kamochi J, Abe Y, Takagi A, Mine T, Yamazaki H, Nakamura M, Ueyama Y. Nagata J, et al. Among authors: yamazaki h. Int J Mol Med. 2002 Oct;10(4):423-6. Int J Mol Med. 2002. PMID: 12239588

5

Ribozyme mediated cleavage of cell-associated isoform of vascular endothelial growth factor inhibits liver metastasis of a pancreatic cancer cell line.

Tokunaga T, Abe Y, Tsuchida T, Hatanaka H, Oshika Y, Tomisawa M, Yoshimura M, Ohnishi Y, Kijima H, Yamazaki H, Ueyama Y, Nakamura M. Tokunaga T, et al. Among authors: yamazaki h. Int J Oncol. 2002 Nov;21(5):1027-32. Int J Oncol. 2002. PMID: 12370751

6

Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.

Tobita K, Kijima H, Dowaki S, Kashiwagi H, Ohtani Y, Oida Y, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S, Makuuchi H. Tobita K, et al. Among authors: yamazaki h. Int J Mol Med. 2003 Mar;11(3):305-9. Int J Mol Med. 2003. PMID: 12579331

7

Reversal of drug resistance mediated by hammerhead ribozyme against multidrug resistance-associated protein 1 in a human glioma cell line.

Osada H, Tokunaga T, Abe Y, Asai S, Miyachi H, Hatanaka H, Tsugu A, Kijima H, Yamazaki H, Shima K, Ueyama Y, Osamura Y, Nakamura M. Osada H, et al. Among authors: yamazaki h. Int J Oncol. 2003 Apr;22(4):823-7. Int J Oncol. 2003. PMID: 12632074

8

Ribozyme mediated down-regulation of thrombospondin receptor CD36 inhibits the growth of the human osteosarcoma cell line.

Yamazaki H, Handa A, Nishi M, Tokunaga T, Tomisawa M, Hatanaka H, Abe Y, Kijima H, Ueyama Y, Nakamura M. Yamazaki H, et al. Oncol Rep. 2004 Feb;11(2):371-4. Oncol Rep. 2004. PMID: 14719070

9

Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.

Kijima H, Yamazaki H, Nakamura M, Scanlon KJ, Osamura RY, Ueyama Y. Kijima H, et al. Among authors: yamazaki h. Int J Oncol. 2004 Mar;24(3):559-64. Int J Oncol. 2004. PMID: 14767540

10

Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer.

Oida Y, Yamazaki H, Tobita K, Mukai M, Ohtani Y, Miyazaki N, Abe Y, Imaizumi T, Makuuchi H, Ueyama Y, Nakamura M. Oida Y, et al. Among authors: yamazaki h. Oncol Rep. 2006 Sep;16(3):457-63. Oncol Rep. 2006. PMID: 16865243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,140 results

Search Page

Filters